Prolonged binding between intratumor Tregs and CD11+ DCs selectively impacts CD8+ T cell activation, leading to reduced levels of IFN-γ, CD44, and Granzyme B, as well as decreased tumor size and increased overall survival [103]. Here, CD8A is linked to neoplasm.